CompletedNot Applicable

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

United States75 participantsStarted 2022-01-14

Plain-language summary

The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Prior tricuspid valve prosthesis
✕. Pacemaker/defibrillator that would impede MRI imaging
✕. Planned tricuspid valve surgery
✕. Primary liver pathology

What they're measuring

Incidence of Severity of tricuspid regurgitation by cardiac magnetic resonance imaging

Timeframe: 1 year

Trial details

NCT IDNCT05006443

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-12

View on ClinicalTrials.gov More Tricuspid Regurgitation trials